J Stroke.  2023 May;25(2):311-314. 10.5853/jos.2023.00325.

Early Administration of Edoxaban After Acute Ischemic Stroke in Patients With Non-valvular Atrial Fibrillation: A Pilot Randomized Trial

• Kim JS
• Lee KB
• Chang DI
• Cha JK
• Lee JS

• KMID: 2542484
• DOI: http://doi.org/10.5853/jos.2023.00325

Reference

References

1. Hart RG, Coull BM, Hart D. Early recurrent embolism associated with nonvalvular atrial fibrillation: a retrospective study. Stroke. 1983; 14:688–693.

2. Heidbuchel H, Verhamme P, Alings M, Antz M, Hacke W, Oldgren J, et al. EHRA practical guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation: executive summary. Eur Heart J. 2013; 34:2094–2106.

3. Bruins Slot KM, Berge E. Factor Xa inhibitors versus vitamin K antagonists for prevention of cerebral or systemic embolism in patients with atrial fibrillation. Stroke. 2018; 49:e235–e236.

4. Munn D, Abdul-Rahim AH, Fischer U, Werring DJ, Robinson TG, Dawson J. A survey of opinion: when to start oral anticoagulants in patients with acute ischaemic stroke and atrial fibrillation? Eur Stroke J. 2018; 3:355–360.

5. Hong KS, Kwon SU, Lee SH, Lee JS, Kim YJ, Song TJ, et al. Rivaroxaban vs warfarin sodium in the ultra-early period after atrial fibrillation–related mild ischemic stroke: a randomized clinical trial. JAMA Neurol. 2017; 74:1206–1215.

6. Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL, et al. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2013; 369:2093–2104.

7. Oldgren J, Åsberg S, Hijazi Z, Wester P, Bertilsson M, Norrving B. Early versus delayed non-vitamin K antagonist oral anticoagulant therapy after acute ischemic stroke in atrial fibrillation (TIMING): a registry-based randomized controlled noninferiority study. Circulation. 2022; 146:1056–1066.

8. Fischer U, Trelle S, Branca M, Salanti G, Paciaroni M, Ferrari C, et al. Early versus Late initiation of direct oral Anticoagulants in post-ischaemic stroke patients with atrial fibrillatioN (ELAN): protocol for an international, multicentre, randomised-controlled, two-arm, open, assessor-blinded trial. Eur Stroke J. 2022; 7:487–495.

9. Best JG, Arram L, Ahmed N, Balogun M, Bennett K, Bordea E, et al. Optimal timing of anticoagulation after acute ischemic stroke with atrial fibrillation (OPTIMAS): protocol for a randomized controlled trial. Int J Stroke. 2022; 17:583–589.

10. King BT, Lawrence PD, Milling TJ, Warach SJ. Optimal delay time to initiate anticoagulation after ischemic stroke in atrial fibrillation (START): Methodology of a pragmatic, response-adaptive, prospective randomized clinical trial. Int J Stroke. 2019; 14:977–982.